Australia’s medicines regulator has approved the Novavax Covid-19 vaccine for use in adults.
Nuvaxovid received provisional approval from the Therapeutic Goods Administration on Thursday, making it the fourth vaccine to be included in Australia’s rollout and the country’s first approved protein-based Covid vaccine.